Physician profile
Andreas Stefan
NPI 1831299460
$2,375.62
in general payments reported to CMS, 2019-2025
19 companies · $787 in 2025
The $787 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.57 · 2020: $17.16 · 2021: $220 · 2022: $57.94 · 2023: $559 · 2024: $637 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $810.62 | 2019-2025 | Axios, Exalt Model D, X-Tack Endoscopic Helix Tacking System |
| Cook Medical LLC | $371.57 | 2023-2025 | Fusion, D.A.S.H., Hemospray |
| Fujifilm Healthcare Americas Corporation | $221.32 | 2025 | |
| Steris Corporation | $154.71 | 2024 | |
| Abbvie INC. | $127.22 | 2023-2025 | Skyrizi |
| Janssen Scientific Affairs, LLC | $121.60 | 2021 | |
| Lilly USA, LLC | $111.82 | 2024-2025 | Omvoh |
| Janssen Biotech, INC. | $105.47 | 2022-2025 | Tremfya |
| Genzyme Corporation | $91.93 | 2023-2024 | |
| Gilead Sciences, INC. | $83.26 | 2025 | Livdelzi |
| Ardelyx, INC. | $32.49 | 2024 | Ibsrela |
| Novo Nordisk INC | $28.08 | 2025 | Wegovy |
| Aimmune Therapeutics, INC. | $27.20 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.31 | 2025 | Gattex |
| Conmed Corporation | $19.18 | 2023 | Conmed Biliary |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17.16 | 2020 | |
| Merck Sharp & Dohme LLC | $13.71 | 2023 | Dificid |
| Ferring Pharmaceuticals INC. | $13.22 | 2022 | |
| Ambu INC. | $4.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Stefan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.